Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has seen a positive revision in its normalized Funds From Operations (NFFO) estimates, with an increase to $4.80 per share for 2025 from a previous estimate of $4.69 per share, aligning with the midpoint of management's guidance. The company's outlook appears strengthened by continued operational success and effective management strategies, contributing to an anticipated increase in the 2026 FFO estimate, which has been raised to $5.03 per share. This upward momentum in financial forecasts reflects the robust revenue generation capabilities of its Real Estate Investments and Senior Housing Operating Portfolio segments, projecting a favorable outlook for the company’s future performance.

Bears say

National Health Investors Inc. faces a negative outlook primarily due to expected lower earnings growth driven by the challenges associated with operator transitions and potential issues within its Senior Housing Operating Portfolio (SHOP) segment. Additionally, risks related to lower-than-anticipated rent resets from its NHC leases and the possibility of deferred rent collections being weaker exacerbate this concern. The company may also encounter operational difficulties if any of its operators face significant challenges, particularly in light of potential health crises like pandemics which could further impact its revenue streams.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.